ModuLight.bio
Optogenetics-based Platform for Neuro-excitatory Conditions
Active
Seed
Startup
Ramat Gan
Founded 2022-04
Modulight is developing an optogenetics-based platform for treating neuronal overactivation disorders, regardless of their specific underlying cause. The company aims to revolutionize the treatment of severe neurological conditions for millions of people worldwide.
SectorHealth Tech & Life Sciences
StageSeed
Total raised$6.7M
Employees31
Founded2022-04
HQRamat Gan
Patents1
Confidence87
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals